Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1990 2
1991 1
1992 1
1993 3
1994 7
1995 1
1996 1
1997 2
1998 4
2000 3
2001 3
2002 3
2003 8
2004 5
2005 7
2006 8
2007 10
2008 12
2009 9
2010 4
2011 3
2012 5
2013 7
2014 5
2015 11
2016 5
2017 9
2018 7
2019 15
2020 11
2021 19
2022 20
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Izutsu K, Makita S, Nosaka K, Yoshimitsu M, Utsunomiya A, Kusumoto S, Morishima S, Tsukasaki K, Kawamata T, Ono T, Rai S, Katsuya H, Ishikawa J, Yamada H, Kato K, Tachibana M, Kakurai Y, Adachi N, Tobinai K, Yonekura K, Ishitsuka K. Izutsu K, et al. Among authors: morishima s. Blood. 2023 Mar 9;141(10):1159-1168. doi: 10.1182/blood.2022016862. Blood. 2023. PMID: 36150143 Free PMC article. Clinical Trial.
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H. Okuno Y, et al. Among authors: morishima s. Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21. Nat Microbiol. 2019. PMID: 30664667
A Comprehensive Study of the Immunophenotype and its Clinicopathologic Significance in Adult T-Cell Leukemia/Lymphoma.
Tamaki T, Karube K, Sakihama S, Tsuruta Y, Awazawa R, Hayashi M, Nakada N, Matsumoto H, Yagi N, Ohshiro K, Nakazato I, Kitamura S, Nishi Y, Miyagi T, Yamaguchi S, Nakachi S, Morishima S, Masuzaki H, Takahashi K, Fukushima T, Wada N. Tamaki T, et al. Among authors: morishima s. Mod Pathol. 2023 Aug;36(8):100169. doi: 10.1016/j.modpat.2023.100169. Epub 2023 Mar 29. Mod Pathol. 2023. PMID: 36997002 Free article.
Mechanisms of action and resistance in histone methylation-targeted therapy.
Yamagishi M, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T, Makiyama J, Suzuki K, Seki M, Abe K, Imamura K, Watanabe E, Tsuchiya K, Yasumatsu I, Takayama G, Hizukuri Y, Ito K, Taira Y, Nannya Y, Tojo A, Watanabe T, Tsutsumi S, Suzuki Y, Uchimaru K. Yamagishi M, et al. Among authors: morishima s. Nature. 2024 Mar;627(8002):221-228. doi: 10.1038/s41586-024-07103-x. Epub 2024 Feb 21. Nature. 2024. PMID: 38383791 Free PMC article.
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.
Umino K, Morita K, Ikeda T, Kawaguchi SI, Nagayama T, Ito S, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kimura SI, Kako S, Doki N, Ozawa Y, Mori Y, Eto T, Hiramoto N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Nakasone H, Morishima S, Kanda Y. Umino K, et al. Among authors: morishima s. Blood. 2023 Sep 14;142(11):1008-1021. doi: 10.1182/blood.2023019799. Blood. 2023. PMID: 37363859
Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma.
Inoue Y, Morishima S, Kato K, Ito A, Nakano N, Kuriyama T, Kawakita T, Mori Y, Suehiro Y, Itonaga H, Miyazaki Y, Imada K, Tomori S, Kanda J, Ichinohe T, Atsuta Y, Fukuda T, Yoshimitsu M; ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy. Inoue Y, et al. Among authors: morishima s. Bone Marrow Transplant. 2023 Sep;58(9):980-990. doi: 10.1038/s41409-023-02002-7. Epub 2023 May 12. Bone Marrow Transplant. 2023. PMID: 37173417
[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists].
Muramatsu I, Suzuki F, Tanaka T, Yamamoto H, Morishima S. Muramatsu I, et al. Among authors: morishima s. Yakugaku Zasshi. 2006 Mar;126 Spec no.:187-98. doi: 10.1248/yakushi.126.187. Yakugaku Zasshi. 2006. PMID: 16518082 Free article. Review. Japanese.
Race and Survival in Unrelated Hematopoietic Cell Transplantation.
Morishima Y, Morishima S, Stevenson P, Kodera Y, Horowitz M, McKallor C, Malkki M, Spellman SR, Gooley T, Petersdorf EW; on-behalf-of-the-International Histocompatibility-Working-Group-in-Hematopoietic-Cell-Transplantation. Morishima Y, et al. Among authors: morishima s. Transplant Cell Ther. 2022 Jul;28(7):357.e1-357.e6. doi: 10.1016/j.jtct.2022.03.026. Epub 2022 Apr 8. Transplant Cell Ther. 2022. PMID: 35405366 Free PMC article.
The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy.
Fuji S, Inoue Y, Makiyama J, Nakano N, Ito A, Kawakita T, Eto T, Suehiro Y, Itonaga H, Sawayama Y, Mori Y, Uchida N, Morishima S, Onizuka M, Ishitsuka K, Fukuda T, Atsuta Y, Yoshimitsu M. Fuji S, et al. Among authors: morishima s. Bone Marrow Transplant. 2023 Jun;58(6):729-731. doi: 10.1038/s41409-023-01969-7. Epub 2023 Mar 25. Bone Marrow Transplant. 2023. PMID: 36966214 No abstract available.
203 results